InhaleRx Limited (AU:IRX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
InhaleRx Limited has announced a significant change in the director’s interests, with Director James Barrie acquiring 492,792 fully paid ordinary shares in lieu of accrued director fees, valued at $16,500. This move reflects the company’s ongoing adjustments in its governance and financial strategies.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.